Marriott International is poised to become the world’s biggest hotel chain as it has announced its intention to purchase its rival Starwood. The Washington Post said the USD12.2 billion stock and cash deal will make the newly-formed company the largest hotelier in the world by a wide margin, at 5,500 properties with over a million rooms all over the world. The deal will also cause both Starwood’s Sheraton, Westin and St. Regis brands to unite with Marriott’s Courtyard, Ritz-Carlton, Fairfield Inn brands.
In a statement, Marriott executive chairman J.W. Marriott, Jr said, "We have competed with Starwood for decades and we have also admired them. I'm excited we will add great new hotels to our system and for the incredible opportunities for Starwood and Marriott associates."
Prior to the merger, Mashable said Starwood’s future came in jeopardy after its CEO abruptly resigned. In April of this year, the hotel chain said it was looking at strategic opportunities in a bid to turn around its flagging growth. One of them was a potential sale.


Trump Calls for 10% Credit Card Interest Rate Cap Starting 2026
FCC Approves Expansion of SpaceX Starlink Network With 7,500 New Satellites
UBS Upgrades L’Oréal to Buy, Sees Strong Sales Momentum and 20% Upside
Supreme Court to Hear Cisco Appeal on Alien Tort Statute and Human Rights Liability
Walmart to Join Nasdaq-100 Index as It Replaces AstraZeneca Following Exchange Move
SK Hynix Shares Hit Record High as AI Memory Demand Fuels Semiconductor Rally
Samsung Forecasts Strong Q4 Profit on AI-Driven Memory Chip Boom
Elon Musk Says X Will Open-Source Its Algorithm Amid EU Scrutiny
Hanwha Ocean Shares Rise on Plans to Expand U.S. Shipbuilding Capacity
Boeing 737 MAX 10 Advances in FAA Testing as Certification Delays Continue
Ford Targets Level 3 Autonomous Driving by 2028 with New EV Platform and AI Innovations
Trump Pushes $100 Billion U.S. Oil Investment Plan for Venezuela After Maduro Seizure
GM Takes $6 Billion EV Write-Down as Electric Vehicle Demand Slows in the U.S.
China’s AI Sector Pushes to Close U.S. Tech Gap Amid Chipmaking Challenges
Aktis Oncology Prices Upsized IPO at $18, Raising $318 Million in Major Biotech Debut
Johnson & Johnson Secures Tariff Exemption by Agreeing to Lower Drug Prices in the U.S.
OpenAI Sets $50 Billion Stock Grant Pool, Boosting Employee Equity and Valuation Outlook 



